1. Home
  2. Analysis
  3. Ciprofloxacin
  4. Kesimpta

Ciprofloxacin and Kesimpta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ciprofloxacin (ciprofloxacin) and Kesimpta (ofatumumab). Common drug interactions include balance disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Ciprofloxacin and Kesimpta. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Ciprofloxacin?

Ciprofloxacin has active ingredients of ciprofloxacin. It is often used in urinary tract infection. eHealthMe is studying from 22,256 Ciprofloxacin users. Check the latest studies of Ciprofloxacin.

What is Kesimpta?

Kesimpta has active ingredients of ofatumumab. eHealthMe is studying from 36,591 Kesimpta users. Check the latest studies of Kesimpta.

On Jul, 03, 2026

16 people who take Ciprofloxacin and Kesimpta together, and have interactions are studied.

Ciprofloxacin and Kesimpta drug interactions.

What are the common drug interactions of Ciprofloxacin and Kesimpta, by gender? *:

female:

n/a

male:

  1. Balance disorder
  2. Dyspnoea (difficult or laboured respiration)
  3. Peripheral swelling
  4. Poor quality sleep
  5. Rib fracture
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Lower respiratory tract infection
  8. Intervertebral disc protrusion (spinal disc protrusion)
  9. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  10. Cardiovascular disorder (heart diseases)

What are the common drug interactions of Ciprofloxacin and Kesimpta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 16 people, 100.00%
  2. Lower Respiratory Tract Infection: 11 people, 68.75%
  3. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 6.25%
  4. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.25%
  5. Fever: 1 person, 6.25%
  6. Birth Control: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ciprofloxacin and Kesimpta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ciprofloxacin and Kesimpta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ciprofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kesimpta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ciprofloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kesimpta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin and ofatumumab (the active ingredients of Ciprofloxacin and Kesimpta, respectively), and Ciprofloxacin and Kesimpta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.